Roberto Borea

13PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 21, 2026
Subtype-Agnostic Biomarkers of Immunotherapy Response in Lung Cancer.

|Dec 28, 2025
Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022.

Luís Felipe Leite, Lucas Diniz da Conceição, Erick F Saldanha

|Sep 22, 2025
Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship.

Roberto Borea, Luca Arecco, Simone Nardin

|Jun 24, 2024
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer.

Luca Arecco, Roberto Borea, Isotta Martha Magaton

|Oct 28, 2023
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition.

Graziana Scavone, Silvia Ottonello, Eva Blondeaux

|May 14, 2022
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients.

Bruna Dalmasso, Alberto Puccini, Fabio Catalano

Pageof 3

Frequent Collaborators

4 joint publications

Matteo Lambertini

4 joint publications

Giuseppe Fornarini

4 joint publications

Sara Elena Rebuzzi

3 joint publications

Luca Arecco